Summitry LLC’s Allergan Inc AGN Stock Holding History

Summitry LLC’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-65,189	Closed	-$20.4M	–	86
2015 Q4	$20.4M	Buy	+65,189	New	+$20.4M	2.16%	24

Other funds holding AGN

Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return

Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return

Mitchell McLeod Pugh & Williams Mobile, Alabama $815M AUM 30.42% 1-Year Est. Return

Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return

Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return

Accuvest Global Advisors Provo, Utah $116M AUM 2.72% 1-Year Est. Return

Summitry LLC's AGN Position: Q1 2016 in Review

Summitry LLC sold out of Allergan Inc (AGN) in Q1 2016, closing a stake of 65,189 shares — an estimated $20.4M sold.

Summitry LLC first reported a position in AGN in Q4 2015 and held it in 1 quarter. The position peaked at $20.4M in Q4 2015. 23 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

Summitry LLC reported no remaining Allergan Inc position as of Q1 2016 after selling out during the quarter.
Summitry LLC sold 65,189 Allergan Inc shares in Q1 2016, an estimated $20.4M.
Summitry LLC first reported a position in Allergan Inc in Q4 2015 and held it in 1 quarter.
Summitry LLC's Allergan Inc position peaked at $20.4M in Q4 2015.
23 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2016.

Based on Summitry LLC's 13F filing for Q1 2016, filed 12 May 2016.